# US 2023/0272006 A1 · Peptidomimetics and method of synthesis thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0272006 A1
- Document ID: US20230272006A1
- Status: Published application
- Kind: A1
- Application number: 18/143,282
- Filed: 2023-05-04
- Published: 2023-08-31
- Earliest claimed: 2021-08-31
- Assignees: The Florida International University Board of Trustees
- Inventors: Adel NEFZI
- Web page: https://patentgrep.com/patent/US20230272006A1

## CPC

- C07K 7/02: Linear peptides containing at least one abnormal peptide link
- C07K 7/08: having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)
- C07C 279/22: Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
- C07K 7/06: having 5 to 11 amino acids
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

The subject invention provides compounds, peptidomimetics, and methods of synthesis thereof. The subject invention provides the synthesis and use of guanidino acids and/or poly guanidino acids not only as vehicles for drug delivery but as toolbox for drug discovery. The peptidomimetic of the subject invention comprises oligo(guanidino acid)s or poly(guanidino acid)s with guanidines as peptide bond surrogates. The incorporation of the guanidine as amide bond surrogates offers significant differences in polarity, hydrogen bonding capability, and acid-base character.

## Claims

### Claim 1

A peptidomimetic having a general structure of:
wherein
a≥1; b≥1; and n≥1;
R1 and R5 are each selected from hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocycloalkyl, substituted heterocycloalkyl, cycloalkenyl, substituted cycloalkenyl, alkenyl substituted alkenyl, alkynyl, haloalkyl, acyl, substituted acyl, —SRa, —NRcRb, —C(═NRb)—NRcRb, —ORd and hydroxylalkyl, wherein Ra, Rc, Rb, and Rd are each independently selected from hydrogen, —NH2, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, heterocycloalkyl, substituted heterocycloalkyl, haloalkyl, and acyl;
R2 is selected from hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocycloalkyl, substituted heterocycloalkyl, cycloalkenyl, substituted cycloalkenyl, alkenyl substituted alkenyl, alkynyl, haloalkyl, acyl, substituted acyl, —SRa, —NRcRb, —ORd and hydroxylalkyl;
each R3 is selected from amino acid side chains and can be present or absent, or R2 and R3 taken together with the nitrogen atom and carbon atom to which they are connected, form a substituted 3- to 8-membered heterocyclic ring;
each R4 is selected from amino acid side chains and can be present or absent, or R4 on the alpha or beta position and the adjacent R6 taken together with the nitrogen atom and carbon atom to which they are connected, form a substituted or unsubstituted 3- to 8-membered heterocyclic ring;
each X is independently selected from —NR6— and —NR6—C(═NR6)—NR6—, and at least one X is —NR6—C(═NR6)—NR6,
and each R6 is selected from hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocycloalkyl, substituted heterocycloalkyl, cycloalkenyl, substituted cycloalkenyl, alkenyl substituted alkenyl, alkynyl, haloalkyl, acyl, substituted acyl, —SRa, —NRcRb, —ORd and hydroxylalkyl.

### Claim 2 (depends on 1)

The peptidomimetic of claim 1, a and each b being 1-10; and n being 1-20.

### Claim 3 (depends on 1)

The peptidomimetic of claim 1, R1 being hydrogen, alkyl, acyl, or guanidine.

### Claim 4 (depends on 1)

The peptidomimetic of claim 1, R2 being hydrogen or alkyl.

### Claim 5 (depends on 1)

The peptidomimetic of claim 1, wherein R5 is —SRa, —NRcRb, or —ORd, wherein Ra, Rc, Rb, and Rd are each independently selected from hydrogen, —NH2, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, heterocycloalkyl, substituted heterocycloalkyl, haloalkyl, and acyl.

### Claim 6 (depends on 1)

The peptidomimetic of claim 1, wherein the peptidomimetic has a structure of:
wherein each X is independently selected from —NH— and —NH—C(═NH)—NH—, and at least one X is —NH—C(═NH)—NH—.

### Claim 7 (depends on 1)

The peptidomimetic of claim 1, wherein the peptidomimetic has a structure of:

### Claim 8 (depends on 1)

The peptidomimetic of claim 1, wherein peptidomimetic is selected from

### Claim 9 (depends on 1)

The peptidomimetic of claim 1, wherein peptidomimetic is selected from

### Claim 10

A method for synthesizing a peptidomimetic comprising one or more guanidino acids, the method comprising:
1. contacting an amino acid with a guanilidation reagent to form a protected guanidino acid that comprises a guanidine with one or more protection groups;
2. removing the one or more protection groups of the protected guanidino acid;
3. mixing the deprotected guanidino acid with a pre-protected amino acid to couple the pre-protected amino acid to the guanidine of the guanidino acid;
4. removing the protection of the product of step 3);
5. optionally, treating the product of step 4) with the guanilidation reagent; and
6) repeating steps 2) to 4), or 3) to 4).

### Claim 11 (depends on 10)

The method of claim 10, the amino acid being a natural or non-natural, modified or non-modified amino acid.

### Claim 12 (depends on 10)

The method of claim 10, the guanilidation reagent having a structure of
wherein L is a leaving group selected from halogen, —SMe, pyrazole, substituted pyrazole, and ammonium; P1 and P2 are orthogonal protecting groups each independently selected from fluorenylmethoxycarbonyl (Fmoc), tert-butyloxycarbonyl (Boc), benzyl chloroformate (Cbz), acetyl (Ac), trifluoroacetyl (TFA), phthalimide, benzyl (Bn), trityl (Trt), benzylideneamine, and tosyl (Ts).

### Claim 13 (depends on 10)

The method of claim 10, the guanilidation reagent being selected from N-Boc-N′-TFA-pyrazole-1-carboxamidine
1,3-Bis(tert-butoxycarbonyl)-2-methyl-2-thiopseudourea
and 1,3-Bis(tert-butoxycarbonyl)guanidine

### Claim 14 (depends on 10)

The method of claim 10, the protected amino acid comprising a protection group selected from for example, fluorenylmethoxycarbonyl (Fmoc), tert-butyloxycarbonyl (Boc), benzyl chloroformate (Cbz), acetyl (Ac), trifluoroacetyl (TFA), phthalimide, benzyl (Bn), trityl (Trt), benzylideneamine, and tosyl (Ts).

### Claim 15 (depends on 10)

The method of claim 10, the protected amino acid being natural or non-natural, modified or non-modified amino acids.

### Claim 16

A method for synthesizing a peptidomimetic, the method comprising:
preparing one or more pre-protected guanidino acids comprising one or more protection groups at the guanidine;
coupling the one or more pre-protected guanidino acids in a stepwise manner in the presence of a coupling reagent; and
removing the one or more protection groups.

### Claim 17 (depends on 16)

The method of claim 16, preparing one or more pre-protected guanidino acids comprising contacting an amino acid with a guanilidation reagent, the amino acid being natural or non-natural, modified or non-modified amino acids.

### Claim 18 (depends on 17)

The method of claim 17, the guanilidation reagent having a structure of
wherein L is a leaving group selected from halogen, —SMe, pyrazole, substituted pyrazole, and ammonium; P1 and P2 are orthogonal protecting groups each independently selected from fluorenylmethoxycarbonyl (Fmoc), tert-butyloxycarbonyl (Boc), benzyl chloroformate (Cbz), acetyl (Ac), trifluoroacetyl (TFA), phthalimide, benzyl (Bn), trityl (Trt), benzylideneamine, and tosyl (Ts).

### Claim 19 (depends on 17)

The method of claim 17, the guanilidation reagent being selected from N-Boc-N′-TFA-pyrazole-1-carboxamidine
1,3-Bis(tert-butoxycarbonyl)-2-methyl-2-thiopseudourea
and 1,3-Bis(tert-butoxycarbonyl)guanidine

### Claim 20 (depends on 16)

The method of claim 16, the coupling reagent being selected from N,N-disubstituted carbodiimides, acyl chloride, acyl fluoride, anhydrides, BOP, PyBOP, PyAOP, PyOxim, TOTU, TSTU, COMU, DEPBT, HBTU, HATU, PyAOP, and HCTU.
